Diagnamed Holdings Corp. (DMED.CN)
CAD 0.03
(20.0%)
CAD 0.03
(20.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | 24.71 | 16.06 |
| Gross Profit | - | -24.71 | -16.06 |
| Operating Expenses | 1.17 Million | 1.13 Million | 683.66 Thousand |
| Selling, General and Administrative Expenses | 662.91 Thousand | 572.83 Thousand | 481.89 Thousand |
| Research and Development Expenses | 514.74 Thousand | 562.85 Thousand | 201.77 Thousand |
| Other Expenses | - | - | - |
| Cost and Expenses | 1.17 Million | 1.13 Million | 683.66 Thousand |
| Operating Income | -1.17 Million | -1.13 Million | 580.48 Thousand |
| Interest Expense | - | - | - |
| Income Tax Expense | - | -4394.69 | 1.26 Million |
| Earnings before Tax | -1.27 Million | -1.13 Million | -1.94 Million |
| Net Income | -1.27 Million | -1.13 Million | -1.94 Million |
| Earnings Per Share Basic | -0.02 | -0.01 | -0.03 |
| Earnings Per Share Diluted | -0.02 | -0.01 | -0.03 |
| Weighted Average Shares Outstanding | 78.19 Million | 76.22 Million | 76.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.19 Million | 76.22 Million | 76.22 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -100.27 Thousand | - | - |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 167.03 Thousand | 270.56 Thousand | 155.15 Thousand | 1.25 Million | 236.33 Thousand | 212.58 Thousand |
| Selling, General and Administrative Expenses | 89.15 Thousand | 139.68 Thousand | 100.67 Thousand | - | 114.69 Thousand | 128.85 Thousand |
| Research and Development Expenses | 77.88 Thousand | 130.88 Thousand | 54.47 Thousand | - | 121.63 Thousand | 83.72 Thousand |
| Other Expenses | 10.79 Thousand | - | - | - | - | - |
| Cost and Expenses | 167.03 Thousand | 270.56 Thousand | 155.15 Thousand | 1.25 Million | 236.33 Thousand | 212.58 Thousand |
| Operating Income | -167.04 Thousand | -270.57 Thousand | -155.15 Thousand | -1.25 Million | -164.13 Thousand | -231.16 Thousand |
| Interest Expense | 51.45 Thousand | - | - | - | - | - |
| Income Tax Expense | -156.24 Thousand | -253.49 Thousand | -147.73 | -1177.66 | 66.08 Thousand | -18.77 Thousand |
| Earnings before Tax | -220.62 Thousand | -126.61 Thousand | 39.86 Thousand | -1.27 Million | -302.64 Thousand | -194 Thousand |
| Net Income | -220.62 Thousand | -126.61 Thousand | 39.86 Thousand | -1.27 Million | -302.64 Thousand | -194 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | 0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | 0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 80.05 Million | 80.05 Million | 80.05 Million | 78.19 Million | 80.05 Million | 79.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 80.05 Million | 80.05 Million | 80.05 Million | 78.19 Million | 80.05 Million | 79.33 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -167.04 Thousand | -270.57 Thousand | -155.15 Thousand | - | -164.13 Thousand | -231.16 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
EPIT
SCRSF
300243
VKAL
3678
4290